Monsanto Can Help Your Portfolio Grow

 

It's understandable why biotech is such a hot sector. An aging U.S. population provides a powerful demographic backdrop for increased demand for drugs and therapies, and large pharmaceutical companies are looking to snap up promising biotech stars to augment their skimpy new drug pipelines.

Although many investors associate biotech with companies that are developing treatments for cancer, diabetes and other life-threatening illnesses, few turn their attention to agriculture and nutrition. Monsanto (MON), for instance, is a supplier of agricultural chemicals, but the company is also a global leader in the development and marketing of seeds and biotechnology traits (related to weed, insect control, weather resistance and improved nutrition) to the world's crop growers.

Green Pastures

And while most biotech companies are still far from profitability, let alone break-even levels of cash flow, Monsanto became solidly profitable in its seeds and genomics business in its last fiscal year ended August 2003. Its free cash flow is expected to be $230 million after dividends this year, more than 100% of estimated net income. Trading at a P/E ratio of 18.3 times the consensus earnings estimate of $1.86 per share for 2005, it seems a little pricey by the chemical sector's standards. But the stock looks like a deal compared to the average biotech company's P/E of 40.

Considering that Monsanto's biotech seeds directly address farm productivity and economics, it's hard to imagine how the company's seeds and genomics business won't continue to be a big success, despite the political and environmental concerns that have arisen over the widespread use of genetically modified seeds. The company has developed seeds and genetic material that can be used to develop seed varieties that provide protection against herbicides (like the company's own best-selling Roundup brand) and insects such as the tobacco budworm, bollworm and corn rootworm. This enables growers to use more productive farming methods like conservation tillage and reduce their reliance on pesticides.

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,776.59 1,340.98 2,906.52 19.78
Oil *
117.31
DOWN
113.87
DOWN
10.97
DOWN
20.71
DOWN
0.69
10 Yr
1.98%
SPDR Gold
167.14
-0.88%
-0.81%
-0.71%
-3.37%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet